Building a Smarter Physician Engagement Strategy for Complex Therapies

Gosia Leitch
VP of Engagement Solutions
Engagement Solutions

“Just by stacking data, you get inconsistencies... Missing data, holes, and biases that need to be accounted for to produce actionable insights.”

Sarah Heming, VP of Strategic Marketing at Diaceutics | Brand Strategy

In today’s competitive launch environment, timing isn’t everything. It’s the edge. Budgets are getting tighter, and access to physicians is more restricted. And yet the rise of more complex therapies continues, with commercial teams needing to do more with less. A smarter physician engagement strategy is what's needed.

Yet many are still relying on fragmented or delayed data. Disconnected engagement tactics, and traditional field models are not enough to reach the right physicians. The result? Missed opportunities, slower uptake, and patients who never make it to treatment.

The solution? DXRX Signal and Physician Engage software. We understood the challenges and designed our software to meet these challenges head-on. Together, they enable the orchestration of a smarter physician engagement strategy. And with this, faster activation of the right physicians at the moment of relevance.

PLAY VIDEO
play
The Access Crisis: Why Traditional Models Are Breaking

Physician access has changed dramatically:

In this environment, even the best field team can’t consistently show up at the right time with the right message. To succeed, brands need a new physician engagement strategy. A new model that activates physicians at the moment of relevance, not the end of a campaign calendar.

 

Precision Engagement Starts With Smarter Data

As Jordan Clark, Chief Data Officer at Diaceutics, shared during our recent webinar:

“Just by stacking data, you get inconsistencies… missing data, holes, and biases that need to be accounted for to produce actionable insights.”

Too often, teams assume that combining claims, EHR, lab, genomic, and SDOH data will create clarity. But without standardization, timeline alignment, and bias correction, it simply increases noise.

Our multimodal AI engine integrates lab, genomic, claims, and EHR data. This delivers real-time, actionable insights that outperform traditional targeting.

 
When Physician Activation Gets Smarter, Results Follow

Across therapy areas, brands using structured physician signals and targeted activation strategies are seeing measurable commercial outcomes.

Here’s what smarter engagement looks like in action:

  • - Precision Oncology
    A top 10 pharma brand saw a 35.6% increase in new patient starts within six months by activating physicians through patient-specific signal triggers.
  • - Cardiovascular Therapy
    Mapping care teams using multimodal data led to a 19% increase in actionable HCP targets, improving engagement across roles beyond the prescriber.
  • - Rare Disease
    A genomic-targeted program identified 88 eligible patients compared to just 8 found via traditional claims-based targeting.
  • - Hematologic Oncology
    One biopharma company grew market share by 8% in 12 months by delivering education at the point of clinical decision—not weeks later.
 
From Information to Activation: A Paradigm Shift

As Gunjan Aggarwal noted in the same webinar:
“We’re at an inflection point where data no longer follows decisions—it drives them.”

The implication is clear: what you know matters less than when and how you act on it. Engagement must move beyond static campaigns and field force timing to dynamic, data-informed decision points.

 
Physician Engagement Strategy: What This Means for You

If your therapy requires precise eligibility, cross-specialty coordination, or is at risk of underutilization due to timing gaps, this model applies to you.

Whether you’re launching a new therapy or reinvigorating an existing brand, DXRX Signal and Physician Engage offer the tools to activate smarter, faster, and more effectively.

About Diaceutics

We’ve been with pharma and biotech companies for over 20 years, helping them to make more informed diagnostic and therapeutic decisions based on real-world data. Our platforms and tools provide global insight from a network of laboratories across 50+ countries.

This unparalleled visibility into real-world testing helps support therapy programs across oncology, cardiology, neurology, autoimmune, rare diseases, and many more.

What is a physician engagement strategy?

A physician engagement strategy is how a brand decides which physicians to reach, when, and with what message. Traditional field models and fragmented or delayed data often miss the right physicians. Diaceutics' DXRX Signal and Physician Engage software help orchestrate a smarter strategy, with faster activation of the right physicians at the moment of relevance.

Why are traditional physician engagement models struggling?

Access has changed dramatically. Over 60% of U.S. physicians now restrict or limit rep access, according to the AMA's 2023 Physician Practice Benchmark Survey. Nearly half of HCP engagement now happens through non-personal channels, which are increasingly crowded and often ignored, according to Veeva's 2023 report. Even the best field team can't consistently show up at the right time with the right message.

Why does stacking claims, EHR, lab and genomic data not automatically create clarity?

Stacking data creates inconsistencies, missing data, holes and biases. Without standardization, timeline alignment and bias correction, combining datasets simply increases noise. Diaceutics' multimodal AI engine integrates lab, genomic, claims and EHR data to deliver real-time, actionable insights that outperform traditional targeting.

How do DXRX Signal and Physician Engage work together?

They are designed to meet access and data challenges head-on. Together they enable brands to activate the right physicians at the moment of relevance, not at the end of a campaign calendar.

What results can smarter physician activation deliver?

 

  • Precision oncology: a top 10 pharma brand saw a 35.6% increase in new patient starts within six months using patient-specific signal triggers.
  • Cardiovascular therapy: mapping care teams with multimodal data led to a 19% increase in actionable HCP targets.
  • Rare disease: a genomic-targeted program identified 88 eligible patients, versus 8 found through claims-based targeting.
  • Hematologic oncology: one biopharma company grew market share by 8% in 12 months by delivering education at the point of clinical decision.
Which brands benefit most from precision physician engagement?
Brands whose therapy requires precise eligibility, needs cross-specialty coordination, or is at risk of underutilization due to timing gaps. This applies whether they are launching a new therapy or reinvigorating an existing brand.
Written By Gosia Leitch
Leading our Engagement Solutions, Gosia designs and delivers data-driven HCP engagement strategies that help pharma partners unlock the full potential of diagnostically driven therapies and accelerate biomarker and treatment adoption. Since joining Diaceutics in 2024, Gosia has been pivotal in scaling Engagement Solutions, sharpening our commercial proposition and driving deeper utilisation of genomics and oncology diagnostics across global pharma accounts. With 20+ years in diagnostics and pharma, including senior roles at Veracyte, Abbott and Bayer, Gosia brings expertise in commercial strategy, brand management and HCP education. She holds an MBA from the University of Iowa and executive education in Corporate Strategy from Columbia Business School.
Read more by this author
Share:

Newsletter sign up

Sign up to our bi-weekly newsletter covering the latest insights to optimize commercialization of diagnostic driven therapies to help empower your decisions.

READY TO DO COMMERCIALIZATION DIFFERENTLY?

Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find them so more people get the right therapy sooner.